Unit
The Biomaterial Laboratory for Immunoengineering at EPFL, led by Dr. Li Tang, focuses on immunoengineering to develop safe and effective therapies against cancer and infectious diseases. Their research program includes reprogramming immune cell metabolism, achieving tissue-specific immune modulation, and manipulating mechanical properties for enhanced immunotherapy.